氯普噻噸雜質(zhì)Ⅰ(氯普噻噸E-異構(gòu)體)
|
PCL-#-Ch372-25mg
|
≥95% 雜質(zhì)對照品 |
113-59-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
氯氮?雜質(zhì)Ⅱ(7-氯-5-苯基-1,3-二氫山4-苯并二氮雜萆-2-酮-4-氧化物)
|
PCL-#-Chp0421-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0421-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
氯氮?雜質(zhì)Ⅱ(7-氯-5-苯基-1,3-二氫山4-苯并二氮雜萆-2-酮-4-氧化物)
|
PCL-#-Chp0421-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0421-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
氯氮?雜質(zhì)Ⅰ(2-氨基-5-氯二苯酮)
|
PCL-#-Chp0420-50mg
|
≥95% 雜質(zhì)對照品 |
719-59-5 |
50mg
|
咨詢
|
咨詢 |
PCL |
氯氮?雜質(zhì)Ⅰ(2-氨基-5-氯二苯酮)
|
PCL-#-Chp0420-25mg
|
≥95% 雜質(zhì)對照品 |
719-59-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
氯硝西泮雜質(zhì)Ⅰ(2-氨基-2'-氯-5-硝基二苯酮)
|
PCL-#-Chp0419-50mg
|
≥95% 雜質(zhì)對照品 |
2011-66-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
氯硝西泮雜質(zhì)Ⅰ(2-氨基-2'-氯-5-硝基二苯酮)
|
PCL-#-Chp0419-25mg
|
≥95% 雜質(zhì)對照品 |
2011-66-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
氯諾昔康雜質(zhì)Ⅰ
|
PCL-#-Chp0418-50mg
|
≥95% ,雜質(zhì)對照品 |
504-29-0 |
50mg
|
¥ 600.0
|
現(xiàn)貨 |
PCL |
氯諾昔康雜質(zhì)Ⅰ(2-氨基吡啶)
|
PCL-#-Chp0418-25mg
|
≥95% 雜質(zhì)對照品 |
504-29-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
氯化琥珀膽堿雜質(zhì)Ⅰ(氯化膽堿)
|
PCL-#-Chp0417-50mg
|
≥95% 雜質(zhì)對照品 |
67-48-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
氯化琥珀膽堿雜質(zhì)Ⅰ(氯化膽堿)
|
PCL-#-Chp0417-25mg
|
≥95% 雜質(zhì)對照品 |
67-48-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
紫杉醇雜質(zhì)Ⅲ(7-表-紫杉醇)(2aR ,4R ,4aS ,6R ,9S , llS ,12aR,12bS )- l ,2a ,3 ,4 ,4a ,6 ,9,10,11,12,12a,12b)-十二氫-4,6,9,11,12,12b-六羥基-4a,8,13,13-四甲基-7,11-亞甲基-5H-環(huán)芳癸[ 3,4 ]苯并[ 1,2-b]氧雜環(huán)丁烷-5酮-6,12b-二醋酸酯,12-苯甲酸酯,9-(2R,3S) -N-苯甲酰-3-苯基異絲氨酸酯
|
PCL-#-Chp0416-50mg
|
≥95% 雜質(zhì)對照品 |
105454-04-4 |
50mg
|
咨詢
|
咨詢 |
PCL |
紫杉醇雜質(zhì)Ⅲ(7-表-紫杉醇)(2aR ,4R ,4aS ,6R ,9S , llS ,12aR,12bS )- l ,2a ,3 ,4 ,4a ,6 ,9,10,11,12,12a,12b)-十二氫-4,6,9,11,12,12b-六羥基-4a,8,13,13-四甲基-7,11-亞甲基-5H-環(huán)芳癸[ 3,4 ]苯并[ 1,2-b]氧雜環(huán)丁烷-5酮-6,12b-二醋酸酯,12-苯甲酸酯,9-(2R,3S) -N-苯甲酰-3-苯基異絲氨酸酯
|
PCL-#-Chp0416-25mg
|
≥95% 雜質(zhì)對照品 |
105454-04-4 |
25mg
|
咨詢
|
咨詢 |
PCL |
紫杉醇雜質(zhì)Ⅱ(7-表-10-去乙?;仙即迹?2aR,4R,4aS,6R,9S,llS,12aR,12bS )- l,2a,3,4,4a,6,9,10,11,12,12a,12b-十二氫-4,6,9,11,12,12b-六羥基-4a,8,13,13-四甲基-7,11-亞甲基-5H-環(huán)芳癸[ 3,4 ]苯并[1,2-b]氧雜環(huán)丁烷- 5酮-12b-醋酸酯,12-苯甲酸酯,9-(2R,3S)-N-苯甲酰-3-苯基異絲氨酸酯
|
PCL-#-Chp0415-50mg
|
≥95% 雜質(zhì)對照品 |
78454-17-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
紫杉醇雜質(zhì)Ⅱ(7-表-10-去乙酰基紫杉醇)(2aR,4R,4aS,6R,9S,llS,12aR,12bS )- l,2a,3,4,4a,6,9,10,11,12,12a,12b-十二氫-4,6,9,11,12,12b-六羥基-4a,8,13,13-四甲基-7,11-亞甲基-5H-環(huán)芳癸[ 3,4 ]苯并[1,2-b]氧雜環(huán)丁烷- 5酮-12b-醋酸酯,12-苯甲酸酯,9-(2R,3S)-N-苯甲酰-3-苯基異絲氨酸酯
|
PCL-#-Chp0415-25mg
|
≥95% 雜質(zhì)對照品 |
78454-17-8 |
25mg
|
咨詢
|
咨詢 |
PCL |
紫杉醇雜質(zhì)Ⅰ(三尖杉寧堿)
|
PCL-#-Chp0414-50mg
|
≥95% 雜質(zhì)對照品 |
71610-00-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
紫杉醇雜質(zhì)Ⅰ(三尖杉寧堿)
|
PCL-#-Chp0414-25mg
|
≥95% 雜質(zhì)對照品 |
71610-00-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
硫酸特布他林雜質(zhì)Ⅰ(3,5-二羥基-ω-叔丁氨基苯乙酮)
|
PCL-#-Chp0413-50mg
|
≥95% 雜質(zhì)對照品 |
139508-58-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
硫酸特布他林雜質(zhì)Ⅰ(3,5-二羥基-ω-叔丁氨基苯乙酮)
|
PCL-#-Chp0413-25mg
|
≥95% 雜質(zhì)對照品 |
139508-58-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
硫酸氫氯吡格雷雜質(zhì)Ⅲ(—)-R-2-[(2-氯苯基)]-2 -(4,5,6,7-四氫噻吩并[3 ,2-c]吡啶-5-基)乙酸甲酯硫酸鹽
|
PCL-#-Chp0412-50mg
|
≥95% 雜質(zhì)對照品 |
120202-71-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
硫酸氫氯吡格雷雜質(zhì)Ⅲ(—)-R-2-[(2-氯苯基)]-2 -(4,5,6,7-四氫噻吩并[3 ,2-c]吡啶-5-基)乙酸甲酯硫酸鹽
|
PCL-#-Chp0412-25mg
|
≥95% 雜質(zhì)對照品 |
120202-71-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
硫酸氫氯吡格雷雜質(zhì)Ⅱ(± ) 2 - [(2 -氯苯基)]-2-(4,5,6,7-四氫噻吩并[2 ,3-c ]吡啶-6-基)乙酸甲酯鹽酸鹽
|
PCL-#-Chp0411-50mg
|
≥95% 雜質(zhì)對照品 |
144750-52-7/1396607-35-4 |
50mg
|
咨詢
|
咨詢 |
PCL |
硫酸氫氯吡格雷雜質(zhì)Ⅱ(± ) 2 - [(2 -氯苯基)]-2-(4,5,6,7-四氫噻吩并[2 ,3-c ]吡啶-6-基)乙酸甲酯鹽酸鹽
|
PCL-#-Chp0411-25mg
|
≥95% 雜質(zhì)對照品 |
144750-52-7/1396607-35-4 |
25mg
|
咨詢
|
咨詢 |
PCL |
硫酸氫氯吡格雷雜質(zhì)Ⅰ( + )2-[S-(2-氯苯基)]-2 -(4,5,6,7-四氫噻吩并[3 ,2-c]吡啶-5-基)乙酸鹽酸鹽)
|
PCL-#-Chp0410-50mg
|
≥95% 雜質(zhì)對照品 |
1015247-88-7 |
50mg
|
咨詢
|
咨詢 |
PCL |